GCG and type 2 diabetes mellitus: DPP-4 inhibitors are commonly used to treat type 2 diabetes, because they enhance circulating levels of incretins, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), to enhance insulin secretion4.